Clinical Trials Logo

Urinary Tract Infections clinical trials

View clinical trials related to Urinary Tract Infections.

Filter by:

NCT ID: NCT01803919 Terminated - Clinical trials for Urinary Tract Infection

Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients

ESCALE
Start date: November 2012
Phase: N/A
Study type: Interventional

The purpose of this trial is to make a comparison between the use of antiseptic silver alloy-coated silicone urinary catheters and the use of conventional silicone urinary catheters in spinal cord injured patients to prevent urinary infections.

NCT ID: NCT01803191 Completed - Clinical trials for Urinary Tract Infections

Efficacy Study of Prophylaxis With Fosfomycin Versus Ciprofloxacin Prior Prostate Biopsy

BIPROST
Start date: August 2012
Phase: Phase 4
Study type: Interventional

The purpose of this clinical trial is compare the incidence of symptomatic or asymptomatic bacteriuria after transrectal ultrasound guided prostate biopsy using a single dose of fosfomycin 3 g one hour before the biopsy compared to observed with the use of a single dose of ciprofloxacin 500 mg 1 hour before biopsy.

NCT ID: NCT01800799 Completed - Clinical trials for Urinary Tract Infection

Urinary NGF as A Biomarker for Acute Bacterial Cystitis

Start date: February 2013
Phase: N/A
Study type: Interventional

This study will enroll 30 female patients with the first time urinary tract infection (UTI), 30 female patients with recurrent UTI and 10 female without any prior history of UTI or urinary tract pathology will be invited to serve as the controls. Urine samples will be collected in the patients at baseline, 7 days after antibiotics treatment, and 2 weeks, 4 weeks, 8 weeks, and 12 weeks. Urinalysis will be performed at each visit and urine culture will be performed at baseline and at the 2 weeks and 3 months visits. Urine samples at baseline and 3 months will be collected from the controls for comparison.

NCT ID: NCT01780324 Completed - Clinical trials for Need for Urethral Catheterization to Rule Out Urinary Tract Infection.

Lidocaine Analgesia for Urethral Catheterization in Children

Start date: January 2013
Phase: N/A
Study type: Interventional

Primary Aim 1. To measure difference in pain via Faces, Legs, Activity, Cry and Consolability (FLACC) Pain Scale score at the time of transurethral bladder catheterization for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization. Secondary Aims 1. To assess gender differences in pain control during transurethral bladder catheterization with and without pain control using intraurethral 2% lidocaine jelly. 2. To assess patient discomfort with administration of intraurethral 2% lidocaine jelly. To assess parental impression of discomfort between intervention and control groups. 3. To assess pain associated with the administration of intraurethral 2% lidocaine jelly. 4. To measure difference in pain via Modified Behavioral Pain Scale (MBPS) score at the time of TUBC for urine collection in children who do and do not receive intraurethral 2% lidocaine jelly prior to catheterization.

NCT ID: NCT01776021 Completed - Infection Clinical Trials

Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections

Start date: January 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effects of a cranberry juice beverage on rates of Urinary tract infection (UTI) recurrence in women with a history of UTI.

NCT ID: NCT01773824 Completed - Clinical trials for Urinary Tract Infections

Routine Prescription Feedback and Peer Comparison to Lower Antibiotic Prescriptions in Primary Care

Start date: October 2013
Phase: N/A
Study type: Interventional

To evaluate the effect of a continuous postal and web-based feedback and peer comparison system of individual antibiotic prescription rates on the prescription behaviour of primary care physicians in Switzerland.

NCT ID: NCT01763008 Completed - Clinical trials for Urinary Tract Infection

A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections

Start date: November 2009
Phase: Phase 4
Study type: Observational

The purpose of this study is to assess the safety and effectiveness of doripenem treatment among Filipino patients with nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infection.

NCT ID: NCT01760109 Completed - Clinical trials for Urinary Tract Infections

Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for Treatment of Respiratory and Urinary System Infection

PIP-SBT
Start date: July 2011
Phase: Phase 4
Study type: Interventional

In the proposed study, the investigators plan to evaluate the efficacy and safety of Piperacillin Sodium and Sulbactam Sodium for Injection(2:1) for the treatment of respiratory and urinary tract acute bacterial infection.

NCT ID: NCT01745328 Recruiting - Clinical trials for Recurrent Urinary Tract Infection

Treatment of Recurrent Urinary Tract Infection (RUTI) by Traditional Chinese Medicine

Start date: January 2009
Phase: N/A
Study type: Interventional

Traditional Chinese Medicine (TCM) could be used to treat Recurrent urinary tract infection (RUTI).

NCT ID: NCT01726166 Terminated - Clinical trials for Neonatal Urinary Tract Infection

Suprapubic Aspiration Versus Urinary Catheterization In Neonates.

SPA
Start date: April 2013
Phase: N/A
Study type: Interventional

Urinary tract infection (UTI) is relatively common in infants, with an occurence rate of up to 10%. Analysis of collected urine for the presence of bacteria or fungus is the only way to make a certain UTI diagnosis. Sterile collection of urine can be achieved in newborn infants by urinary catheterization (UC) where a catheter is passed through the urethra into the bladder, suprapubic aspiration (SPA) where a needle is inserted into the bladder through the abdominal wall, or 'clean catch' where urine is collected into a sterile bottle as the baby urinates during preparation for UC. The main advantage of SPA is that it bypasses the bacteria that normally resides in the urethral opening, thus minimizing the risk of contamination. Some studies have suggested that SPA is better than UC for collecting urine in a sterile fashion in the neonate due to the difficulty of doing sterile UC in small infants resulting in more contaminated samples (also called a false-positive urine culture); there is still no clear best choice. UC is commonly used in many Neonatal Intensive Care Units (NICU) as it is considered less invasive, can be done by the nursing staff, and generally has a higher chance of obtaining urine. SPA is a simple and safe alternative and, although it may be more painful than UC, it is performed more quickly. The reported success rate for SPA is variable, but is greatly increased when an ultrasound confirms urine in the bladder. The question remains: what is the best method for sterile collection of urine in neonates? In this study, the investigators will try to answer this question by collecting urine from neonates using either ultrasound guided SPA or UC and then comparing the contamination rates between these two methods. The investigators hypothesize that SPA will result in less contamination of urine samples. The investigators also hypothesize that there will be more success in obtaining an adequate urine sample (0.5 ml) by SPA, and that there will be no difference in associated complication rates between SPA and UC.